InspireMD Inc/ US45779A8466 /
2024-07-29 9:59:55 PM | Chg. +0.01 | Volume | Bid- | Ask- | High | Low |
---|---|---|---|---|---|---|
3.37USD | +0.30% | 180 Turnover: 598.60 |
-Bid Size: - | -Ask Size: - | 3.37 | 3.29 |
GlobeNewswire
07-01
InspireMD Announces Full Exercise of Series H Warrant Tranche for Gross Proceeds of $17.9 Million
GlobeNewswire
05-28
InspireMD Announces Presentation of Positive One-Year Follow-Up Results from the C-GUARDIANS U.S. In...
GlobeNewswire
05-14
InspireMD Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
05-07
InspireMD to Report First Quarter 2024 Financial Results and Provide Corporate Business Update on Tu...
GlobeNewswire
03-26
InspireMD Announces Abstract of One-Year Follow-Up Results from the C-GUARDIANS U.S. Investigational...
GlobeNewswire
03-06
InspireMD Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update
GlobeNewswire
02-28
InspireMD to Report Fourth Quarter and Full-Year 2023 Financial Results and Provide Corporate Busine...
GlobeNewswire
02-12
InspireMD Appoints Principal Investigators for C-GUARDIANS II Clinical Trial of the SwitchGuard™ Neu...
GlobeNewswire
01-31
InspireMD Receives CE Mark Recertification Under EU’s New Medical Device Regulation (MDR) Regulatory...
GlobeNewswire
01-03
InspireMD Announces Appointment of Medical Technology Executive Pete Ligotti as Executive Vice Presi...
GlobeNewswire
2023-12-20
InspireMD Announces Issuance of Key U.S. Patent Covering Its SwitchGuard™ Neuroprotection System
GlobeNewswire
2023-11-27
InspireMD Announces Strategic Agreement with Jacobs Institute to Execute Early Feasibility Study of ...
GlobeNewswire
2023-11-06
InspireMD Reports Third Quarter 2023 Financial Results and Provides Business Update
GlobeNewswire
2023-11-01
InspireMD Presents Positive 30-Day Follow-Up Results from the C-GUARDIANS U.S. Investigational Devic...
GlobeNewswire
2023-10-30
InspireMD to Report Third Quarter 2023 Financial Results and Provide Corporate Business Update on Mo...
GlobeNewswire
2023-10-12
InspireMD Supports CMS’ Final National Coverage Determination (NCD) Expanding Coverage of Carotid St...
GlobeNewswire
2023-10-03
InspireMD Announces Senior Leadership Changes to Support Commercial Growth Initiatives
GlobeNewswire
2023-08-31
InspireMD Announces Abstract of 30-Day Results from the C-Guardians U.S. Investigational Device Exem...
GlobeNewswire
2022-03-16
InspireMD to Host Key Opinion Leader Event on Carotid Artery Disease Management and Stroke Preventio...
GlobeNewswire
2022-02-28
InspireMD Announces the Inclusion of its CGuard Carotid Stent in CREST-2 Trial Following FDA Approva...